Acrivon Therapeutics Inc

ACRVNASDAQ · US

Holders

REDUCEDT+2
Peterson Katharine
Acrivon Therapeutics Inc · NASDAQ
−101 sh · $203
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Blume-Jensen Peter
Acrivon Therapeutics Inc · NASDAQ
−1,229 sh · $2.5K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Gamelin Erick
Acrivon Therapeutics Inc · NASDAQ
−400 sh · $804
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Devroe Eric
Acrivon Therapeutics Inc · NASDAQ
−604 sh · $1.2K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Miller Mary
Acrivon Therapeutics Inc · NASDAQ
−185 sh · $372
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Blume-Jensen Peter
Acrivon Therapeutics Inc · NASDAQ
−484 sh · $973
Filed 20 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Two Sigma Investments
Acrivon Therapeutics Inc · NASDAQ
389,395 sh · $541.3K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Renaissance Technologies
Acrivon Therapeutics Inc · NASDAQ
758,440 sh · $1.1M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Acrivon Therapeutics Inc · NASDAQ
767,020 sh · $4.4M
Filed 30 Jun 2024SEC 13Fview source